PRSS1 intron mutations in patients with pancreatic cancer and chronic pancreatitis

Molecular Medicine Reports

Volumn 5, Issue 2, 2012, Pages 449-451

  Gao, Feng ^a   Liu, Qi Cai ^a   Zhang, Sheng ^a   Zhuang, Ze Hao ^a   Lin, Cai Zhu ^a   Lin, Xin Hua ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Chronic pancreatitis; Mutations; Pancreatic cancer; PRSS1 gene

Indexed keywords

CATIONIC TRYPSINOGEN; GENOMIC DNA; TRYPSINOGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CHRONIC PANCREATITIS; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); DIAGNOSTIC PROCEDURE; DNA EXTRACTION; EXPOSURE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; RISK ASSESSMENT; SEQUENCE ANALYSIS; SMOKING; STRUCTURED QUESTIONNAIRE;

COHORT STUDIES; FEMALE; HUMANS; INTRONS; MALE; MUTATION; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SMOKING; TRYPSIN;

EID: 84862956952     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.684     Document Type: Article

References (18)

1. Farrow B and Evers BM: Inflammation and the development of pancreatic cancer. Surg Oncol 10: 153-169, 2002. (Pubitemid 34520439)
2. Hengstler JG, Bauer A, Wolf HK, Bulitta CJ, Tanner B, Oesch F, Gebhard S and Boettger T: Mutation analysis of the cationic trypsinogen gene in patients with pancreatic cancer. Anticancer Res 20: 2967-2974, 2000.
3. Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley R, Uomo G, Delhaye M, Spicak J, Drumm B, Jansen J, Mountford R, Whitcomb DC and Neoptolemos JP: Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol 2: 252-261, 2004. (Pubitemid 38293313)
4. Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Kloppel G, Longnecker DS, Luttges J and Offerhaus GJ: Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25: 579-586, 2001. (Pubitemid 32423354)
5. Lowenfels AB, Maisonneuve P, Dimagno EP, et al: Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89: 442-446, 1997. (Pubitemid 27136736)
6. Whitcomb DC and Pogue-Geile K: Pancreatitis as a risk for pancreatic cancer. Gastroenterol Clin North Am 31: 663-678, 2002. (Pubitemid 34761231)
7. Jemal A, Siegel R, Ward E, Hao YP, Xu JQ, Murray T and Thun M: Cancer statistics 2008. CA Cancer J Clin 58: 71-96, 2008.
8. Liu QC, Gao F, Ou QS, Zhuang ZH, Yang B and Lin SR: Novel mutation and polymorphism of PRSS1 gene in the Chinese patients with hereditary pancreatitis and chronic pancreatitis. Chin Med J 121: 108-111, 2008. (Pubitemid 351247881)
9. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren SA and Domellof L: Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328: 1433-1437, 1993. (Pubitemid 23143844)
10. Chen JM and Férec C: Chronic pancreatitis: genetics and pathogenesis. Annu Rev Genomics Hum Genet 10: 63-87, 2009.
11. Grocock CJ, Rebours V, Delhaye M, Andren-Sandberg A, Weiss FU, Mountford R, Harcus M, Levy P, Lerch MM and Greenhalf W: European Registry of Hereditary Pancreatitis and Pancreatic Cancer. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families. Gut 59: 357-363, 2010.
12. Liu QC, Zhuang ZH, Zeng K, Cheng ZJ, Gao F and Wang ZQ. Prevalence of pancreatic diabetes in patients carrying mutations or polymorphisms of the PRSS1 gene in the Han population.Diabetes Technol Ther 11: 799-804, 2009.
13. Kinzler KW and Vogelstein B: Landscaping the cancer terrain. Science 280: 1036-1037, 1998. (Pubitemid 28234937)
14. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM and DiMagno EP: Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 286: 169-170, 2001. (Pubitemid 32640846)
15. Friess H, Ding J, Kleeff J, et al: Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg 234: 769-778, 2001.
16. Talamini G, Falconi M, Bassi C, et al: Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol 94: 1253-1260, 1999.
17. Tang Z, Geng G, Huang Q, Xu G, Hu H, Chen J and Li J: Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis. Med Oncol 27: 867-875, 2010.
18. Caruso R, Pallone F, Fina D, Gioia V, Peluso I, Caprioli F, Stolfi C, Perfetti A, Spagnoli LG, Palmieri G, MacDonald TT and Monteleone G: Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor trans-activation and proliferation. Am J Pathol 169: 268-278, 2006.